Results: 110 patients completed all examinations up to 1 year. 58 patients were studied up to 2 years. The refractive results were. very good: C+/-O.4D at one year and -0.05+/0.4D at 2 years for manifest refraction, and 0.37+/-0.8 at one year and 0.25+/-0.7 at 2 years for refmction under cycloplegia. Comeal haze diminished with time up to 2 years (0.24+/-0.4 at one year and 0.12+/-0.3 at 2 years). Them were no statisticdly significant differences between one and 2 years results regarding refraction. uncorrected visual acuity and best corrected visual acuity among the 58 patients seen at 1 and 2 years afta the treatment, although some late regression was seen in very few eyes. Conclusion: The refractive results of PRX appear stable between 1 and 2 years after surgery for low myopia. Corneal clarity still improves with time between one and 2 years after the treatment. The excimer laser used in this study was the visx 20/20 from Visx inc. 108 patients were operated for myopia from -lD to -14.5 D. multiple zones comeal ablation was performed for moderate and high myopias.Topical non steroid anti-inflamatory treatment was systematically used for six months while corticoids were administrated only in case of quick regression or intense haze. Datas of 70 eyes were clinically and statistically evaluated in terms of safety, efficacity and predictibility over a six months follow up period. m.
Results are reported globally and for subgroups of myopia ( group A:SE I 3 D; group B: -3 D < SE< -7 D : group C: SE >-7 D.) One month after the treatment, 25% of cases were at lo/IO and 75% were Z 5/10. at six months, 64% were 2 5/10; in group A 93% were 5 5/10. in group B77% were > 5/10, and in group C, 35% of the cases were 2 5/10. Predictability was satisfactory in particular in groups A and B ( mean deviation: -0.5 d) while in group C, the mean deviation was higher ( -1.7 D). stability is better in patients who originally had a low or moderate moderate myopia. Safety of the treatment was satisfactory;
grade of cornea1 opacity was generally mild and decreasing slightly over the six months, excepted for two patients with moderate persistant haze. B.
The photorefractive keratectomy with visx 20/20 was clinically effective in the treatment of myopia. The results show that this technique is effective, predictable and safe for low and moderate myopias. However, the corrective effect anlNEpredictibility are less accurate in high myopias. Puroose: To evaluate the lone term refractive effects of a 3 month teatkent with dexamethaaone-&er PRK Methods: 50 oatients (mean age 29) have been ueated with the Summit Exci&d laser for myoiia ui to 6D. For each patient. one eye (first or second, randomly determined), has been treated 3 months with dexamethasone, the other eye did not received any treatment. Manifest refraction, refraction under cycloplegia, corneal topography have been shldied at D15. 1.3.6 and 12 months by a masked observer. Results: There was no difference between the two groups regarding preoperative myopia (-3.9+/-1.53D and -3.89+/-1.51D). The refractive results were excellent in both gr0ups.The.m was a statisticsllv sienificant diiference between treated and non treated eyes for CyclEplegic refraction up to 12 months (pcO.01). with treated eyes beeing more corrected (and sometimes more overcorrected). At one year. the difference for manifest refraction was almost significant (p=O.O56). Comeal haze was slightly teduced in the tmated eyes up to 6 months, but then were no more difference at one year between the two groups. Conclusions: A 3 month treatment with Dexamethasone can have an intlwnce on long turn tzfmtive results aftm PRK for myopia s51
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